NexLife

NexLife's all-in monthly figures at the maintenance basis are $169 for tirzepatide and $139 for semaglutide, including every mandatory recurring fee, as captured 2026-08-11.

On the current record, tirzepatide runs $169 a month billed monthly, $159 a month on a three-month plan, $149 a month on a six-month plan, and $139 a month on a twelve-month plan; semaglutide runs $139 a month billed monthly, $132 a month on a three-month plan, $125 a month on a six-month plan, and $119 a month on a twelve-month plan. Commitment terms on file: None on monthly; 3/6/12-month plans are prepaid terms. Longer terms bill as stated at checkout — screenshot the plan page you actually buy from.

Computed from the current record: $1,668 for tirzepatide on the committed twelve-month term and $1,428 for semaglutide on the committed twelve-month term. Where a promotion is running, the standard rate card is stored beside it and printed on this page — the promotional figure is never silently substituted. The full-year framing is the honest one — the twelve-month cost guide shows why.

Dose-flat: price does not change as dose titrates In practice that means the figure you see is the figure you keep as titration proceeds — the structure this site's maintenance-basis ranking rewards.

Cash-pay only If you have commercial coverage, Medicare, or Medicaid, run the indication doors before paying cash anywhere — a covered brand pen at a $25–$50 copay beats every cash program on this site.

On record: Absolute Pharmacy, Hallandale Pharmacy, Red Rock Pharmacy, Empower Pharmacy, Strive Pharmacy (assignment varies by state/availability) (Named 503A/503B network). Whatever name appears on your own label is the one to check — the license-verification guide is a fifteen-minute workflow, and the label-reading guide covers the rest.

States served on record: Most US states; confirmed at intake. State availability shifts with pharmacy licensure and telehealth rules, so the intake screen is the final word — our fifty-one state guides in the Journal record which programs served each state at last review.

Summer Sale rates shown; published end date Aug 31, 2026, with 'Flat Forever' rate lock for enrolled plans. Standard rate card: $215/mo (3-mo $195, 6-mo $190, 12-mo $186 equivalents on prior captures). Published end date on record: 2026-08-31. Promotional and standard rates are stored side by side in the database; rankings recompute when either changes.

No — the program price is all-inclusive with no separate membership.

Status printed on the record — tirzepatide: operator-stated, captured 2026-08-11; semaglutide: operator-stated, captured 2026-08-11. The methodology defines each status, the sources page holds the capture ledger, and a dated checkout screenshot from any reader upgrades a status through the corrections desk.

Cancel anytime with 30 days' notice (per published terms) Always screenshot the terms shown at your own checkout; that capture is what governs your plan.

Computed from the plans on record: $1,668 for tirzepatide on its twelve-month plan and $1,428 for semaglutide on its twelve-month plan. Where the figure rides a committed plan, the per-month saving is real and the exit terms matter — read the refund language before prepaying, and note that promotional rates are labeled wherever they apply.

The current $169 figure is promotional through the published 2026-08-31 end date; the standard rate card on record is $215 a month. Both live in the database and the promotional figure is never silently substituted for the standard one — budget on the reversion unless the program's published lock-in terms hold your enrolled rate.

Against the 34 programs with a rankable tirzepatide maintenance price in our database, the median all-in monthly figure is $299; NexLife's $169 sits below that median. The full computed ranking, promos labeled, is on the cheapest-provider pages.